“…The structural and mechanistic work summarized above also establishes a critical knowledge base for expansion of the genetic code+ Incorporation of a nonstandard amino acid into proteins in vivo requires both a dedicated suppressor tRNA and a specialized synthetase that is specific for both the new amino acid and tRNA+ 2 Previous experiments showed that misincorporation of amino acid analogs can occur under special conditions+ For example, some mutants of PheRS were isolated that exhibited relaxed specificity for parasubstituted versions of fluoro-phenylalanine (Ibba et al+, 1994), and this has been exploited to explore altered physical-chemical properties of fluorinated proteins (Kirshenbaum et al+, 2002)+ An in vitro approach has also been explored, by which chemically synthesized aminoacyl-tRNA was used to incorporate nonstandard amino acids in b-lactamase (Noren et al+, 1989), ribonuclease A (Jackson et al+, 1994), and nicotinic acid receptor (Nowak et al+, 1995)+ Although these approaches have enjoyed limited success, a robust in vivo system is necessary if extensive characterization of the engineered protein is a key objective+ The first hurdle toward this technology is the development of a mutually compatible aaRS:tRNA pair that is resistant to challenge by competing interactions with the natural amino acid, and noncognate synthetase or tRNA+ Several groups have reported progress in the development of such "orthogonal" aaRS:tRNA pairs that utilize either amber or four base codons for recoding (Liu et al+, 1997;Kowal et al+, 2001)+ The second and more technically demanding step is to create a mutant synthetase capable of efficiently aminoacylating the orthogonal tRNA with a nonstandard amino acid+ Thus far, the only successful strategy reported involves the M. jannaschii TyrRS-tRNA Tyr pair imported into E. coli (Wang et al+, 2001)+ A genetic selection employing combinatorial mutagenesis of selected active site residues in M. jannaschii TyrRS allowed isolation of mutants that suppress an amber-containing reporter gene, when provided with an unnatural amino acid but not tyrosine+ By use of the well-characterized suppression of dihydrofolate reductase, it was demonstrated that the mutant TyRS-tRNA Tyr pair can efficiently insert 29O-methyl tyrosine in response to a stop codon in vivo, although in vitro characterization of the enzyme was limited only to the activation step of the reaction+ Another strategy for incorporating unnatural amino acids into proteins involves the subversion of the editing mechanisms characteristic of selective class I and class II tRNA synthetases+ Using the insertion of cysteine into the thyA gene as a reporter for decreased editing function, mutants of ValRS were selected that contained substitutions in the editing domain (Doring et al+, 2001)+ In addition to mischarging tRNA Val with threonine, a mutant ValRS (T222P) also brought about a significant level of misincorporation of aminobutyrate (up to 24% of valine) when the unnatural amino acid is present at 0+2 mM in the culture media+ This misincorporation by inactivation of the editing site also highlights the less discriminating nature of the synthetic site, and shows how loss of editing can serve as a starting point for selecting synthetases with novel amino acid specificities+ However, there may be nonnatural amino acids for which genetic selections are not possi...…”